Journal of Literature Pharmacy Sciences

.: REVIEW
Toksikolojide Toksikogenomikler ve Yeni Gelişmeler
Toxicogenomics and New Advances in Toxicology
Fundanur YAZICIa, Sevtap AYDINa
aFarmasötik Toksikoloji AD, Hacettepe Üniversitesi Eczacılık Fakültesi, Ankara, TÜRKİYE
J Lit Pharm Sci. 2019;8(1):29-42
doi: 10.5336/pharmsci.2018-62249
Article Language: TR
Full Text
ÖZET
 Genom, bir organizmanın içerdiği genlerin bütünüdür. Bu genlerin birbirleri ve çevre ile etkileşimini inceleyen çalışmalar genomik olarak ifade edilmektedir. Genomikler, bir organizmanın genomunun dizilişini ve analizini ilgilendiren bir genetik alanıdır. Omik teknolojileri altında genomik, proteomik ve metabolomik teknolojilerinden söz edilmektedir. Bu tüm yeni yaklaşımlar toksisitenin öngörülmesinde, toksisite oluşumunun altında yatan moleküler olayların anlaşılmasını sağlamaktadır. Toksikogenomik ise insan sağlığı ve çevre üzerine zararlı etmenlere karşı organizmadaki gen ve protein aktivitelerinin incelendiği ve toksikoloji ve genomiğin bir arada yer aldığı toksikolojinin bir alt dalıdır. Gen ekspresyon mikroarray teknolojinin gelişmesiyle binlerce genin transkripsiyon seviyesi aynı anda değerlendirilebilir. DNA mikroarray analizi ve protein chipleri gibi yeni moleküler teknolojiler, binlerce gen ve proteinin aynı anda ekspresyonuna olanak sağlayarak toksisite yolaklarının, spesifik kimyasal ve ilaç hedeflerinin keşfini hızlandırmaktadır. Bu yeni toksikogenomik yöntemler toksikoloji alanının gelişimine de olanak sağlamıştır. Omik teknolojileri tüm transkriptom, proteom ve metabonomun incelenmesine izin vermektedir. Bu nedenle omik çalışmalarda büyük miktarda veri üretilmektedir. Bu durum, veri işleme ve veri analizi için yeni kavramları gerektirmiştir. Biyoinformatik çalışmaları bu alanda önem kazanmıştır. Bu çalışmalar ile büyük veri kümeleri içindeki ve arasındaki ilişkiler çeşitli algoritmalar ve biyoistatistiksel yöntemler ile ortaya çıkarılmaktadır. Sonuç olarak, toksikogenomiğin toksikolojide çok önemli bir yeri bulunmaktadır. Bu çalışmada, toksikolojide yeni toksikogenomik gelişmelerin kapsamlı olarak tartışılması amaçlanmıştır.

Anahtar Kelimeler: Toksikoloji; toksikogenetik; genomlar; proteomlar; omik teknolojileri
ABSTRACT
 A genome is the whole of an organism's genes. Studies that examine the interaction of these genes with each other and with the environment are expressed as "genomics". Genomics is an area within genetics that concerns the sequencing and analysis of an organism's genome. Genomics, proteomics and metabolomics technologies are mentioned under omics technology. All these new approaches provide an understanding of the molecular events that underlie toxicity formation for the prediction of toxicity. Toxicogenomics is a subdisiplin of toxicology, where toxicology and genomics coexist, and gene and protein activities in the organism are examined against harmful agents on human health and the environment. By the development of gene expression microarray technology, thousands of genetic transcription levels can be evaluated at the same time. New molecular technologies, such as DNA microarray analysis and protein chips, accelerates the discoveries of toxic pathways, specific chemical and drug targets by enabling the simultaneous expression of thousands of genes and proteins. These new toxicogenomic methods also enable the development of the field of toxicology. Omics technology allows the investigation of all transcriptomics, proteomics and metabonomics. For this reason, large amounts of data are generated in omics studies. This requires new concepts for data processing and data analysis. Bioinformatics studies have gained importance in this area. The relations between these studies and large data sets are revealed by various algorithms and biostatistical methods. In conclusion, toxicogenomics has a very important place in toxicology. Within this rewiev, the new toxicogenomic developments in toxicology were discussed.

Keywords: Toxicology; toxicogenetics; genomics; proteomics; omic technologies
REFERENCES:
  1. Başaran E, Aras S, Duman D. [Overview of genomic, proteomic and metabolomic terms and their application areas]. Turk Hij Den Biyol Derg. 2010;67(2):8596.
  2. Suter-Dick L, Singer T. Methods in toxicology. In: Greim H, Snyder R, eds. Toxicology and Risk Assessment: A Comprehensive Introduction. 1st ed. West Sussex: John Wiley & Sons; 2008. p.437-49.
  3. Kurban S, Mehmetoğlu İ. [Proteomic]. Yeni Tıp Dergisi. 2010;27(2):70-5.
  4. Hamadeh HK, Amin RP, Paules RS, Afshari CA. An overview of toxicogenomics. Curr Issues Mol Biol. 2002;4(2):45-56.
  5. Borlak J. Application of toxicogenomic: case studies. Handbook of Toxicogenomics. 1st ed. Weinheim: Wiley-VCH; 2005. p.325-486. [Crossref]
  6. Chen M, Zhang M, Borlak J, Tong W. A decade of toxicogenomic research and its contribution to toxicological science. Toxicol Sci. 2012;130(2):217-28. [Crossref]
  7. Suter L, Haiker M, De Vera MC, Albertini S. Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach. Pharmacogenomics J. 2003;3(6):320-34. [Crossref]
  8. Castle AL, Carver MP, Mendrick DL. Toxicogenomics: a new revolution in drug safety. Drug Discov Today. 2002;7(13):728-36. [Crossref]
  9. Waters MD, Olden K, Tennant RW. Toxicogenomic approach for assesing toxicant-related disease. Mut Res. 2003;544(2-3):415-24. [Crossref]
  10. Yuluğ I. [Human genom project]. Avrasya Dosyası Moleküler Biyoloji ve Gen Teknolojileri Özel. 2002;8(3):7-23.
  11. Stanton LW. Methods to profile gene expression. Trends Cardiovasc Med. 2001;11(2):49-54. [Crossref]
  12. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270(5235):467-70. [Crossref]
  13. Özcengiz G. [Proteomic: The most powerful technology of the post-genomic period]. METU Newsletter. 2007;15:13-9.
  14. Mik?ík I. Coupling of CE-MS for protein and peptide analysis. J Sep Sci. 2018 Sep 20. Doi: 10.1002/jssc.201800817. [Epub ahead of print]. [Crossref]
  15. Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Population proteomics: the concept, attributes, and potential for cancer biomarker research. Mol Cell Proteomics. 2006;5(10):1811-8. [Crossref]
  16. Meleady P. Two-dimensional gel electrophoresis and 2D-DIGE. Methods Mol Biol. 2018;1664:3-14. [Crossref]
  17. Huang Y, Zhu H. Protein array-based approaches for biomarker discovery in cancer. Genomics Proteomics Bioinformatics. 2017;15(2):73-81. [Crossref] [PMC]
  18. Venter JC. A part of the human genome sequence. Science 2003;299(5610):1183-4. [Crossref]
  19. German JB, Hammock BD, Watkins SM. Metabolomics: building on a century of biochemistry to guide human health. Metabolomics. 2005;1(1):3-9. [Crossref] [PMC]
  20. Zacharias HU, Altenbuchinger M, Gronwald W. Statistical analysis of NMR metabolic fingerprints: established methods and recent advances. Metabolites. 2018;8(3). [Crossref] [PMC]
  21. Blaženović I, Kind T, Ji J, Fiehn O. Software tools and approaches for compound identification of LCMS/MS data in metabolomics. Metabolites. 2018;8(2). [Crossref] [PMC]
  22. Nedelkov D. Population proteomics: investigation of protein diversity in human populations. Proteomics. 2008;8(4):779-86. [Crossref] [PubMed]
  23. Atalay RÇ. [Why bioinformatics?]. Avrasya Dosyası Moleküler Biyoloji ve Gen Teknolojileri Özel. 2002;8(3):129-41.
  24. Baxevanis AD, Ouellette BFF. Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins. 2nd ed. New York: John Wiley & Sons Inc; 2001. p.470. [Crossref]
  25. Barel G, Herwig R. Network and pathway analysis of toxicogenomics data. Front Genet. 2018;9:484. [Crossref]
  26. Suter L, Babiss LE, Wheeldon EB. Toxicogenomics in predictive toxicology in drug development. Chem Biol. 2004;11(2):161-71. [Crossref]
  27. Gao Y, Cao Z, Yang X, Abdelmegeed MA, Sun J, Chen S, et al. Proteomic analysis of acetaminopheninduced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury. Proteomics Clin Appl. 2017;11(1-2). [Crossref]
  28. Rouquié D, Heneweer M, Botham J, Ketelslegers H, Markell L, Pfister T, et al. Contribution of new technologies to characterization and prediction of adverse effects. Crit Rev Toxicol. 2015;45(2):172-83. [Crossref]
  29. Leclercq I, Horsmans Y, Desager JP, Delzenne N, Geubel AP. Reduction in hepatic cytochrome P450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation. J Hepatol. 1998;28(3):410-6. [Crossref]
  30. Omiecinski CJ, Hassett C, Costa P. Developmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1. Mol Pharmacol. 1990;38(4):462-70.
  31. Barlev NA, Candau R, Wang L, Darpino P, Silverman N, Berger SL. Characterization of physical interactions of the putative transcriptional adaptor, ADA2, with acidic activation domains and TATAbinding protein. J Biol Chem. 1995;270(33):19337-44. [Crossref]
  32. Zhong W, Mirkovitch J, Darnell JE Jr. Tissue-specific regulation of mouse hepatocyte nuclear factor 4 expression. Mol Cell Biol. 1994;14(11): 7276-84. [Crossref]
  33. Gant TW, Baus PR, Clothier B, Riley J, Davies R, Judah DJ, et al. Gene expression profiles associated with inflammation, fibrosis, and cholestasis in mouse liver after griseofulvin. EHP Toxicogenomics. 2003;111(1T):37-43. [Crossref]
  34. Gant TW, Greaves P, Smith AG, Gescher A. Toxicogenomics applied to understanding cholestasis and steatosis in the liver. In: Borlak J, ed. Handbook of Toxicogenomics. 1st ed. Weinheim: Wiley-VCH; 2005. p.369-94. [Crossref]
  35. Thum T, Borlak J. Toxicogenomics applied to cardiovascular toxicity. In: Borlak J, ed. Handbook of Toxicogenomics. 1 st ed. Weinheim: Wiley-VCH; 2005. p.395-412. [Crossref]
  36. Arrell DK, Neverova I, Van Eyk JE. Cardiovascular proteomics: evolution and potential. Circ Res. 2001;88(8):763-73. [Crossref]
  37. Deavall DG, Moggs JG, Orphanides G. Toxicogenomics applied to endocrine disruption. In: Borlak J, ed. Handbook of Toxicogenomics. 1st ed. Weinheim: Wiley-VCH; 2005. p.413-33. [Crossref]
  38. Waters KM, Safe S, Gaido K. Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta, and AR in reproductive tissues of female mice. Toxicol Sci. 2001;(63):47-56. [Crossref]
  39. Hewitt PG, Kramer PJ, Borlak J. Toxicogenomics applied to teratogenicity studies. In: Borlak J, ed. Handbook of Toxicogenomics. 1st ed. Weinheim: Wiley-VCH; 2005. p.435-69. [Crossref]
  40. Rosen MB, Chernoff N. 5-Aza-2?-deoxycytidineinduced cytotoxicity and limb reduction defects in the mouse. Teratology. 2002;65(4):180-90. [Crossref]
  41. Lühe A, Hildebrand H. Toxicogenomics applied to nephrotoxicity. In: Borlak J, ed. Handbook of Toxicogenomics. 1st ed. Weinheim: Wiley-VCH; 2005. p.471-86. [Crossref]
  42. Katsuma S, Shiojima S, Hirasawa A, Takagaki K, Kaminishi Y, Koba M, et al. Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun. 2002;296(3):544-52. [Crossref]
  43. McGregor E, Dunn MJ. Proteomics of the heart: unraveling disease. Circ Res. 2006;98(3):309-21. [Crossref]
  44. Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer. 2003;3(4):267-75. [Crossref]
  45. Qin C, Tanis KQ, Podtelezhnikov AA, Glaab WE, Sistare FD, DeGeorge JJ. Toxicogenomics in drug development: a match made in heaven? Expert Opin Drug Metab Toxicol. 2016;12(8):847-9. [Crossref]
  46. Alexander-Dann B, Pruteanu LL, Oerton E, Sharma N, Berindan-Neagoe I, Módos D, et al. Developments in toxicogenomics: understanding and predicting compound-induced toxicity from gene expression data. Mol Omics. 2018;14(4): 218-36.[Crossref]

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com